Страна: Ирландия
Език: английски
Източник: HPRA (Health Products Regulatory Authority)
Darunavir
Rowex Ltd
J05AE; J05AE10
Darunavir
600 milligram(s)
Film-coated tablet
Product subject to prescription which may not be renewed (A)
Protease inhibitors; darunavir
Not marketed
2017-06-02
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT DARUNAVIR ROWEX 75 MG FILM-COATED TABLETS DARUNAVIR ROWEX 600 MG FILM-COATED TABLETS darunavir READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor, pharmacist or nurse. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Darunavir Rowex is and what it is used for 2. What you need to know before you take Darunavir Rowex 3. How to take Darunavir Rowex 4. Possible side effects 5. How to store Darunavir Rowex 6. Contents of the pack and other information 1. WHAT DARUNAVIR ROWEX IS AND WHAT IT IS USED FOR WHAT IS DARUNAVIR ROWEX Darunavir Rowex contains the active substance darunavir. Darunavir Rowex is an antiretroviral medicine used in the treatment of Human Immunodeficiency Virus (HIV) infection. It belongs to a group of medicines called protease inhibitors. Darunavir Rowex works by reducing the amount of HIV in your body. This will improve your immune system and reduces the risk of developing illnesses linked to HIV infection. WHAT IS IT USED FOR? Darunavir Rowex is used to treat adults and children of 3 years of age and above, and at least 15 kilogram body weight who are infected by HIV and who have already used other antiretroviral medicines. Darunavir Rowex must be taken in combination with a low dose of ritonavir and other anti- HIV medicines. Your doctor will discuss with you which combination of medicines is best for you. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE DARUNAVIR ROWEX DO NOT TAKE DARUNAVIR ROWEX - if you are ALLERGIC to darunavir or any of the other ingredients of this medicine (listed in section 6) Прочетете целия документ
HealthProductsRegulatoryAuthority 13September2019 CRN008V9G Page1of35 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT DarunavirRowex600mgFilm-coatedtablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Eachfilm-coatedtabletcontains600mgdarunavir. Excipient(s) with known effect:Eachtabletcontains2.592mgsunsetyellowFCF(E110) Forthefulllistofexcipients,seesection6.1. 3 PHARMACEUTICAL FORM Film-coatedtablet. Orangeovalshapedfilm-coatedtablet,debossedwith‘600’ononesideandplainontheotherside. Dimensions:approximately20.1mmx10.1mm 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS DarunavirRowex,co-administeredwithlowdoseritonavirisindicatedincombinationwithotherantiretroviralmedicinal productsforthetreatmentofpatientswithhumanimmunodeficiencyvirus(HIV-1)infection(seesection4.2). DarunavirRowextabletsmaybeusedtoprovidesuitabledoseregimens(seesection4.2): ForthetreatmentofHIV-1infectioninantiretroviraltreatment(ART)-experiencedadultpatients,includingthose thathavebeenhighlypre-treated. ForthetreatmentofHIV-1infectioninpaediatricpatientsfromtheageof3yearsandatleast15kgbodyweight. IndecidingtoinitiatetreatmentwithDarunavirRowexco-administeredwithlowdoseritonavir,carefulconsiderationshouldbe giventothetreatmenthistoryoftheindividualpatientandthepatternsofmutationsassociatedwithdifferentagents. Genotypicorphenotypictesting(whenavailable)andtreatmenthistoryshouldguidetheuseofDarunavirRowex(seesection 4.2,4.4and5 Прочетете целия документ